Open access
2,630
Views
0
CrossRef citations to date
0
Altmetric
Novel Vaccines
Immunogenicity and safety of the non-typable Haemophilus influenzae–Moraxella catarrhalis (NTHi-Mcat) vaccine administered following the recombinant zoster vaccine versus administration alone: Results from a randomized, phase 2a, non-inferiority trial
Ilaria Galgania GSK, Siena, ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-6315-4259View further author information
Airi Põderb The Clinical Research Center, Tartu, EstoniaView further author information
, Rain Jõgic The Lung Clinic, Tartu University Hospital, Tartu, EstoniaView further author information
, Veli-Jukka Anttilad Department of Infectious Diseases, Inflammation Center, Helsinki University Hospital and Helsinki University, Helsinki, FinlandView further author information
, Stefano Millerie Centro Ricerche Cliniche di Verona Srl, Verona, ItalyView further author information
, Alberto M. Borobiaf Clinical Pharmacology Department, La Paz University Hospital, IdiPAZ, Madrid, Spain;g School of Medicine, Autonomous University of Madrid, Madrid, Spain;h Spanish Clinical Research Network – SCReN, Madrid, Spain;i Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, SpainView further author information
, Odile Launayj Université Paris Cité, Paris, France;k Inserm CIC 1417, F-CRIN I-REIVAC, Paris, France;l Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, CIC Cochin Pasteur, Paris, FranceView further author information
, Marco Testaa GSK, Siena, ItalyView further author information
, Daniela Casulaa GSK, Siena, ItalyView further author information
, Luca Grassanoa GSK, Siena, ItalyView further author information
, Annaelisa Tasciottia GSK, Siena, ItalyView further author information
, Marie Dozotm GSK, Rixensart, BelgiumView further author information
& Ashwani K. Aroran GSK, Wavre, BelgiumView further author information
show all
Article: 2187194
|
Received 05 Dec 2022, Accepted 01 Mar 2023, Published online: 28 Mar 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.